
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5101235
[patent_doc_number] => 20070184497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Clinical diagnostic reagent and diagnostic method for testing infection of adult taenia solium and taenia saginata'
[patent_app_type] => utility
[patent_app_number] => 10/593032
[patent_app_country] => US
[patent_app_date] => 2005-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2565
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593032
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593032 | Clinical diagnostic reagent and diagnostic method for testing infection of adult taenia solium and taenia saginata | Mar 1, 2005 | Abandoned |
Array
(
[id] => 5101258
[patent_doc_number] => 20070184520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Reduction of spontaneous mutation rates in cells'
[patent_app_type] => utility
[patent_app_number] => 10/590829
[patent_app_country] => US
[patent_app_date] => 2005-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17697
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184520.pdf
[firstpage_image] =>[orig_patent_app_number] => 10590829
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590829 | Reduction of spontaneous mutation rates in cells | Feb 25, 2005 | Abandoned |
Array
(
[id] => 177533
[patent_doc_number] => 07655240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Vaccine composition comprising an immunoadjuvant compound consisting of a Rho GTPase family activator'
[patent_app_type] => utility
[patent_app_number] => 10/589505
[patent_app_country] => US
[patent_app_date] => 2005-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 9701
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655240.pdf
[firstpage_image] =>[orig_patent_app_number] => 10589505
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/589505 | Vaccine composition comprising an immunoadjuvant compound consisting of a Rho GTPase family activator | Feb 24, 2005 | Issued |
Array
(
[id] => 5112963
[patent_doc_number] => 20070196878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Immune diagnostic assay to diagnose and monitor tuberculosis infection'
[patent_app_type] => utility
[patent_app_number] => 10/589692
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15535
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196878.pdf
[firstpage_image] =>[orig_patent_app_number] => 10589692
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/589692 | Immune diagnostic assay to diagnose and monitor tuberculosis infection | Feb 17, 2005 | Issued |
Array
(
[id] => 4807486
[patent_doc_number] => 20080171064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Live Attenuated Salmonella For Use as Vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/589065
[patent_app_country] => US
[patent_app_date] => 2005-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 38439
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171064.pdf
[firstpage_image] =>[orig_patent_app_number] => 10589065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/589065 | Live Attenuated Salmonella For Use as Vaccine | Feb 13, 2005 | Abandoned |
Array
(
[id] => 4797132
[patent_doc_number] => 20080008718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Ornithobacterium Rhinotracheale Subunit Vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/588992
[patent_app_country] => US
[patent_app_date] => 2005-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10094
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20080008718.pdf
[firstpage_image] =>[orig_patent_app_number] => 10588992
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/588992 | Ornithobacterium Rhinotracheale Subunit Vaccines | Feb 8, 2005 | Abandoned |
Array
(
[id] => 5153940
[patent_doc_number] => 20070036823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Development of a live, attenuated, recombinant vaccine for Brucellosis'
[patent_app_type] => utility
[patent_app_number] => 11/050429
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14175
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20070036823.pdf
[firstpage_image] =>[orig_patent_app_number] => 11050429
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/050429 | Development of a live, attenuated, recombinant vaccine for Brucellosis | Feb 3, 2005 | Abandoned |
Array
(
[id] => 7038911
[patent_doc_number] => 20050158345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Streptococcal ABC transporter protein'
[patent_app_type] => utility
[patent_app_number] => 11/037601
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11713
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158345.pdf
[firstpage_image] =>[orig_patent_app_number] => 11037601
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/037601 | Streptococcal ABC transporter protein | Jan 17, 2005 | Abandoned |
Array
(
[id] => 5472984
[patent_doc_number] => 20090246150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'ANTIMICROBIAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 10/596623
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12451
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246150.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596623
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596623 | Antimicrobial composition | Dec 14, 2004 | Issued |
Array
(
[id] => 5894421
[patent_doc_number] => 20060002960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'GM1 binding deficient exotoxins for use as immunoadjuvants'
[patent_app_type] => utility
[patent_app_number] => 11/007282
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 28725
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002960.pdf
[firstpage_image] =>[orig_patent_app_number] => 11007282
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/007282 | GM1 binding deficient exotoxins for use as immunoadjuvants | Dec 8, 2004 | Abandoned |
Array
(
[id] => 5415772
[patent_doc_number] => 20090041659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse'
[patent_app_type] => utility
[patent_app_number] => 10/581564
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12860
[patent_no_of_claims] => 109
[patent_no_of_ind_claims] => 70
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041659.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581564
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581564 | Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse | Dec 2, 2004 | Abandoned |
Array
(
[id] => 7711427
[patent_doc_number] => 08092808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-10
[patent_title] => 'Ovo vaccination of Campylobacter in avian species'
[patent_app_type] => utility
[patent_app_number] => 10/578162
[patent_app_country] => US
[patent_app_date] => 2004-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3467
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/092/08092808.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578162
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578162 | Ovo vaccination of Campylobacter in avian species | Nov 21, 2004 | Issued |
Array
(
[id] => 6960047
[patent_doc_number] => 20050215776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Novel human 7TM proteins and polynucleotides encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/990309
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18991
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215776.pdf
[firstpage_image] =>[orig_patent_app_number] => 10990309
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/990309 | Novel human 7TM proteins and polynucleotides encoding the same | Nov 15, 2004 | Abandoned |
Array
(
[id] => 6906271
[patent_doc_number] => 20050101666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Method of treating premenstrual dysphoric disorder with escitalopram'
[patent_app_type] => utility
[patent_app_number] => 10/984536
[patent_app_country] => US
[patent_app_date] => 2004-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3275
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10984536
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/984536 | Method of treating premenstrual dysphoric disorder with escitalopram | Nov 7, 2004 | Abandoned |
Array
(
[id] => 7098763
[patent_doc_number] => 20050131222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Nucleotide sequence of the haemophilus influenzae Rd genome, fragments thereof, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/981687
[patent_app_country] => US
[patent_app_date] => 2004-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 42898
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20050131222.pdf
[firstpage_image] =>[orig_patent_app_number] => 10981687
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/981687 | Nucleotide sequence of the haemophilus influenzae Rd genome, fragments thereof, and uses thereof | Nov 4, 2004 | Abandoned |
Array
(
[id] => 5807207
[patent_doc_number] => 20060093561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Method of treating microorganisms in the oral cavity'
[patent_app_type] => utility
[patent_app_number] => 10/978424
[patent_app_country] => US
[patent_app_date] => 2004-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7764
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093561.pdf
[firstpage_image] =>[orig_patent_app_number] => 10978424
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/978424 | Method of treating microorganisms in the oral cavity | Nov 1, 2004 | Abandoned |
Array
(
[id] => 6983319
[patent_doc_number] => 20050153389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Method for the production of bioactive substances from the novel actinomycete taxon MAR2 (\"Marinophilus\")'
[patent_app_type] => utility
[patent_app_number] => 10/972530
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3721
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153389.pdf
[firstpage_image] =>[orig_patent_app_number] => 10972530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972530 | Method for the production of bioactive substances from the novel actinomycete taxon MAR2 ("Marinophilus") | Oct 24, 2004 | Abandoned |
Array
(
[id] => 4484556
[patent_doc_number] => 07883709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Stabilised compositions'
[patent_app_type] => utility
[patent_app_number] => 10/576732
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 33
[patent_no_of_words] => 33453
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/883/07883709.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576732
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576732 | Stabilised compositions | Oct 21, 2004 | Issued |
Array
(
[id] => 6930749
[patent_doc_number] => 20050281783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Listeria-based EphA2 vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/966483
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 45715
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10966483
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/966483 | Listeria-based EphA2 vaccines | Oct 14, 2004 | Abandoned |
Array
(
[id] => 6905545
[patent_doc_number] => 20050100940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Novel FDRG protein and nucleic acid molecules and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/955218
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 41189
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100940.pdf
[firstpage_image] =>[orig_patent_app_number] => 10955218
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/955218 | Novel FDRG protein and nucleic acid molecules and uses therefor | Sep 29, 2004 | Abandoned |